Primary outcome
Among patients with a 20% decrease in MAP or MAP < 65 mmHg after administration, the highest incidence was in the P group (n = 55, 56.7%), followed by the R+P group (n = 30, 31.3%), and the lowest incidence was in the RT group (n = 14, 12.6%), with statistical differences among the three groups in pairwise comparison (